Schechter Matthew Adam, Ganapathi Asvin M, Englum Brian R, Speicher Paul J, Daneshmand Mani A, Davis R Duane, Hartwig Matthew G
1 Department of Surgery, Duke University Medical Center, Durham, NC.
Transplantation. 2016 Dec;100(12):2699-2704. doi: 10.1097/TP.0000000000001047.
Extracorporeal membrane oxygenation (ECMO) is being increasingly used as a bridge to lung transplantation. Small, single-institution series have described increased success using ECMO in spontaneously breathing patients compared with patients on ECMO with mechanical ventilation, but this strategy has not been evaluated on a large scale.
Using the United Network for Organ Sharing database, all adult patients undergoing isolated lung transplantation from May 2005 through September 2013 were identified. Patients were categorized by their type of pretransplant support: no support, ECMO only, invasive mechanical ventilation (iMV) only, and ECMO + iMV. Kaplan-Meier survival analysis with log-rank testing was performed to compare survival based on type of preoperative support. A Cox regression model was used to determine whether type of preoperative support was independently associated with survival, using previously established predictors of survival as covariates.
Approximately 12,403 primary adult pulmonary transplantations were included in this analysis. Sixty-five patients (0.52%) were on ECMO only, 612 (4.93%) required only iMV, 119 (0.96%) were on ECMO + iMV, and the remaining 11,607 (94.6%) required no invasive support before transplantation. One-year survival was decreased in all patients requiring support, regardless of type. However, mid-term survival was similar between patients on ECMO alone and those not on support but significantly worse with patients requiring iMV only or ECMO + iMV. In multivariable analysis, ECMO + iMV and iMV alone were independently associated with decreased survival compared with nonsupport patients, whereas ECMO alone was not significant.
In patients with worsening pulmonary disease awaiting lung transplantation, those supported via ECMO with spontaneous breathing demonstrated improved survival compared with other bridging strategies.
体外膜肺氧合(ECMO)越来越多地被用作肺移植的桥梁。小规模的单机构系列研究表明,与接受机械通气的ECMO患者相比,在自主呼吸患者中使用ECMO的成功率更高,但这一策略尚未得到大规模评估。
利用器官共享联合网络数据库,确定了2005年5月至2013年9月期间所有接受单肺移植的成年患者。患者根据移植前支持类型进行分类:无支持、仅ECMO、仅有创机械通气(iMV)以及ECMO+iMV。采用Kaplan-Meier生存分析和对数秩检验来比较基于术前支持类型的生存率。使用Cox回归模型,将先前确定的生存预测因素作为协变量,以确定术前支持类型是否与生存独立相关。
本分析纳入了约12403例原发性成年肺移植患者。65例患者(0.52%)仅接受ECMO支持,612例(4.93%)仅需要iMV,119例(0.96%)接受ECMO+iMV,其余11607例(94.6%)在移植前不需要有创支持。所有需要支持的患者,无论支持类型如何,其1年生存率均降低。然而,单独接受ECMO支持的患者与未接受支持的患者中期生存率相似,但仅需要iMV或ECMO+iMV的患者中期生存率明显更差。在多变量分析中,与无支持患者相比,ECMO+iMV和仅iMV与生存率降低独立相关,而单独的ECMO则无显著意义。
在等待肺移植的肺部疾病恶化患者中,与其他桥接策略相比,通过ECMO支持自主呼吸的患者生存率有所提高。